A Trial Comparing the Effect of Pravastatin and Rosuvastatin on Atherosclerosis Progression Measured by Carotid Intima Media Thickness in Patients With Coronary Artery Disease After Biolimus Eluting Stent (Nobori®) Implantation: CPR IMT

NCT01872845 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

671

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Occlusive Disease

Interventions

DRUG: Pravastatin 40mg
DRUG: Rosuvastatin

Sponsor

Yonsei University